Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cardiff Oncology, Inc. | 650,000 | reported | 04 Jan 2016 | tx 1+150,000 |
| Constellation Alpha Capital Corp. | 158,215 | reported | 01 Jun 2023 | tx 11+144,946−25,696 |
| Talis Biomedical Corp | 95,000 | reported | 09 Jun 2023 | tx 3+252,500 |
| Nautilus Biotechnology, Inc. | 45,000 | reported | 23 Jun 2025 | tx 8+271,467 |
| ILLUMINA, INC. | 7,563 | reported | 30 May 2013 | tx 34+120,720−105,450 |
| HALOZYME THERAPEUTICS, INC. | 6,040 | reported | 05 May 2026 | tx 26+189,681−79,881 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 May 2026 | GRANT_AWARD | HALOZYME THERAPEUTICS, INC. | 3,796 | 0.00 USD | |
| 05 May 2026 | GRANT_AWARD | HALOZYME THERAPEUTICS, INC. | 6,040 | 0.00 USD | deriv |
| 23 Jun 2025 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 45,000 | 0.00 USD | deriv |
| 01 May 2025 | GRANT_AWARD | HALOZYME THERAPEUTICS, INC. | 4,165 | 0.00 USD | |
| 01 May 2025 | GRANT_AWARD | HALOZYME THERAPEUTICS, INC. | 5,750 | 0.00 USD | deriv |
| 13 Aug 2024 | SALE | HALOZYME THERAPEUTICS, INC. | 10,000 | 56.19 USD | |
| 14 Aug 2024 | SALE | HALOZYME THERAPEUTICS, INC. | 9,881 | 57.70 USD | |
| 12 Aug 2024 | SALE | HALOZYME THERAPEUTICS, INC. | 10,000 | 55.72 USD | |
| 14 Jun 2024 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 45,000 | 0.00 USD | deriv |
| 11 Jun 2024 | SALE | HALOZYME THERAPEUTICS, INC. | 10,000 | 50.01 USD | |
| 12 Jun 2024 | SALE | HALOZYME THERAPEUTICS, INC. | 10,000 | 50.62 USD | |
| 25 Apr 2024 | GRANT_AWARD | HALOZYME THERAPEUTICS, INC. | 6,501 | 0.00 USD | |
| 25 Apr 2024 | GRANT_AWARD | HALOZYME THERAPEUTICS, INC. | 8,804 | 0.00 USD | deriv |
| 15 Jun 2023 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 45,000 | 0.00 USD | deriv |
| 09 Jun 2023 | GRANT_AWARD | Talis Biomedical Corp | 95,000 | 0.00 USD | deriv |
| 01 Jun 2023 | GRANT_AWARD | Constellation Alpha Capital Corp. | 35,714 | 0.00 USD | |
| 05 May 2023 | GRANT_AWARD | HALOZYME THERAPEUTICS, INC. | 8,065 | 0.00 USD | |
| 05 May 2023 | GRANT_AWARD | HALOZYME THERAPEUTICS, INC. | 11,371 | 0.00 USD | deriv |
| 06 Dec 2022 | SALE | HALOZYME THERAPEUTICS, INC. | 10,000 | 56.12 USD | |
| 02 Dec 2022 | SALE | HALOZYME THERAPEUTICS, INC. | 10,000 | 58.80 USD | |
| 05 Dec 2022 | SALE | HALOZYME THERAPEUTICS, INC. | 10,000 | 55.74 USD | |
| 15 Jun 2022 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 86,467 | 0.00 USD | deriv |
| 10 Jun 2022 | GRANT_AWARD | Talis Biomedical Corp | 95,000 | 0.00 USD | deriv |
| 26 May 2022 | GRANT_AWARD | Constellation Alpha Capital Corp. | 26,480 | 0.00 USD | |
| 05 May 2022 | GRANT_AWARD | HALOZYME THERAPEUTICS, INC. | 6,206 | 0.00 USD |